Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 11, 2008, Pages 1306-1312

  Tho, Dau Quang ^a   Ha, D T M ^a,b   Duy, P M ^a   Lan, N T N ^b   Hoa, D V ^b   Chau, N V V ^c   Farrar, J ^a,d   Caws, M ^a,d  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b Pham Ngoc Thach Hospital   (Viet Nam)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

MTBDR; PCR; Resistance; Rifampicin; Tuberculosis

Indexed keywords

ISONIAZID; KATG PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ALLELE; AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CODON; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DRUG SENSITIVITY; GENOTYPE; GOLD STANDARD; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; TERTIARY HEALTH CARE; VIET NAM;

EID: 56249128627     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. World Health Organization. Global TB control: surveillance, planning, financing. WHO report 2006. WHO/HTM/TB/2006. 362. Geneva, Switzerland: WHO, 2006.
2. Emergence of Mycobacterium tuberculosis with exrensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55: 301-305.
3. Zignol M, Hosseini M S, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485.
4. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/International Union Against Tuberculosis and Lung Disease global project on drug resistance surveillance, 1994-1997. WHO/TB/97.229. Geneva, Swizerland: WHO, 1997.
5. van Doorn H R, de Haas P E, Kremer K, Vandenbroucke-Grauls C M, Borgdorff M W, van Soolingen D. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. Clin Microbiol Infect 2006; 12: 769-775.
6. Sun Y J, Lee A S, Wong S Y, et al. Genotype and phenotype relationships and transmission analysis of drug-resistant tuberculosis in Singapore. Int J Tuberc Lung Dis 2007; 11: 436-442.
7. Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 2004; 10: 1117-1121.
8. Blower S M, Chou T. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat Med 2004; 10: 1111-1116.
9. Resch S C, Salomon J A, Murray M, Weinstein M C. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med 2006; 3: e241.
10. Caminero J A. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006; 10: 829-837.
11. Gupta R, Irwin A, Raviglione M C, Kim J Y. Scaling up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis. Lancet 2004; 363: 320-324.
12. Baltussen R, Floyd K, Dye C. Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 2005; 331: 1364.
13. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 2005; 5: 62.
14. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43: 3699-3703.
15. Makinen J, Marttila H J, Marjamaki M, Viljanen M K, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 350-352.
16. Soudani A, Hadjfredj S, Zribi M, et al. Characterization of Tunisian Mycobacterium tuberculosis rifampicin-resistant clinical isolates. J Clin Microbiol 2007; 45: 3095-3097.
17. Traore H, van Deun A, Shamputa I C, Rigouts L, Portaels F. Direct detection of Mycobacterium tuberculosis complex DNA and rifampicin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006; 44: 4384-4388.
18. Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampicin. J Clin Microbiol 2006; 44: 4459-4463.
19. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 2006; 44: 3659-3664.
20. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the genotype MTBDR assay for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006; 44: 2338-2342.
21. Caws M, Duy P M, Tho D Q, Lan N T, Hoa D V, Farrar J. Mutations prevalent among rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 2006; 44: 2333-2337.
22. Johansen I S, Lundgren B, Sosnovskaja A, Thomsen V O. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 2003; 41: 4454-4456.
23. Van Rie A, Warren R, Mshanga I, et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 2001; 39: 636-641.
24. Sandman L, Schluger N W, Davidow A L, Bonk S. Risk factors for rifampicin-monoresistant tuberculosis: a case-control study. Am J Respir Crit Care Med 1999; 159: 468-472.
25. Gillespie S H. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 2002; 46: 267-274.
26. Sajduda A, Brzostek A, Poplawska M, et al. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol 2004; 42: 2425-2431.
27. Wada T, Maeda S, Tamaru A, Imai S, Hase A, Kobayashi K. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol 2004; 42: 5277-5285.
28. Bobadilla-del-Valle M, Ponce-de-Leon A, Arenas-Huertero C, et al. rpoB gene mutations in rifampicin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerg Infect Dis 2001; 7: 1010-1013.
29. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampicin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002; 40: 4435-4438.
30. Kapur V, Li L L, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampicin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994; 32: 1095-1098.
31. van Soolingen D, Hermans P W, de Haas P E, Soil D R, van Embden J D. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991; 29: 2578-2586.
32. Heep M, Brandstatter B, Rieger U, et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampicin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001; 39: 107-110.
33. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the genotype MTBDRplus assay for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640.